|Last Price||Today's Change||52-Week Range||Trading Volume|
|8.02||0.01 (+0.12%)||6.36 - 10.32||531.5 thousand (Below Avg)|
Market data as of 3:59PM 09/17/14. Quotes are delayed by at least 15 min.
Spectrum Pharmaceuticals Makes Decision to Advance SPI-2012, a Novel Long-Acting GCSF, to Phase 3 Due to Positive Phase 2 Results in its Collaboration Program with Hanmi Pharm. Co.
09/09/2014 7:00 AM ET